Manufacturers Life Insurance Company, The Day One Biopharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 46,999 shares of DAWN stock, worth $560,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,999
Previous 48,488
3.07%
Holding current value
$560,698
Previous $675,000
11.85%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding DAWN
# of Institutions
175Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$76.7 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$69.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$68.7 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$58.1 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$54.1 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $876M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...